-
Product Insights
ATC – Aluminum RVs and Trailers Manufacturing Plant – Indiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our ATC - Aluminum RVs and Trailers Manufacturing Plant - Indiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
ATC Tires – Atchutapuram Tire Manufacturing Plant – Andhra Pradesh
Equip yourself with the essential tools needed to make informed and profitable decisions with our ATC Tires - Atchutapuram Tire Manufacturing Plant - Andhra Pradesh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Altech – ATC Bahru High Purity Alumina Plant – Johor
Equip yourself with the essential tools needed to make informed and profitable decisions with our Altech - ATC Bahru High Purity Alumina Plant - Johor report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Colorectal Cancer Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Squamous Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Squamous Non-Small Cell Lung Cancer Drug Details: BCA-101 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Oropharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Oropharyngeal Cancer Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Squamous Cell Carcinoma Drug Details: BCA-101 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Hypopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Hypopharyngeal Cancer Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Laryngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Laryngeal Cancer Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Oral Cavity (Mouth) Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Oral Cavity (Mouth) Cancer Drug Details: BCA-101 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Recurrent Head And Neck Cancer Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Recurrent Head And Neck Cancer Squamous Cell Carcinoma Drug Details: BCA-101 is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Solid Tumor Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BCA-101 in Pancreatic Cancer Drug Details: BCA-101 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Foscenvivint in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Foscenvivint in Solid Tumor Drug Details: Foscenvivint is under development for the treatment of HCV...
-
Product Insights
ATC West Mixed-Use Complex
Each construction project profile includes core details such as project name, stage, location, key dates, scope, background and description. Also included are key companies involved in the project such as project owner, planning authority, FEED/design company and main contractor, as well as selected operational metrics. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Company Profile
![]()
American Tower Corp – Company Profile
American Tower Corp (ATC) is a global real estate investment trusts (REITs) and independent operator and developer of multitenant communications real estate. It leases space on communications sites to wireless service providers, wireless data providers, radio and television broadcast companies, government agencies and municipalities and tenants to other industries. The company also works with companies in other industries to help them optimize their wireless communication networks. Its major services include tower-related services, site application, zoning, permitting, construction management and structural...
Add to Basket -
Thematic Analysis
![]()
Mergers and Acquisitions in Tech, Media, and Telecom (TMT) 2022 Themes – Thematic Intelligence
M&A in TMT Thematic Report Overview In 2022, the major themes that impacted the M&A sector in the technology, media, and telecom (TMT) industry were mainly categorized into four segments- hardware, software and services, internet & media, and telecom services. M&A activity in the global TMT sector has been increasing since 2018, but the trend reversed in 2022. In 2022, the software and services sector accounted for more than 57% of the overall TMT M&A deal value. The Mergers and...
-
Sector Analysis
Americas Fibercos and Towercos Market Dynamics and Opportunities
Americas Fibercos and Towercos Market Report Overview Proliferation of 5G deployments in the Americas (mostly in North America) will require significant investment in telecom infrastructure, both in towers and fiber. Considering these investment and coverage imperatives in 5G and FTTH/B, telcos are turning to fibercos and towercos to spur network expansion and asset monetization. Capex reduction and asset monetization are key drivers for telcos to consider opportunities in towercos and fibercos. The Americas Fibercos and Towercos market research report reviews...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – BCA-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BCA-101 Drug Details BCA-101 is under development for the treatment of solid tumors like squamous...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRI-724
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PRI-724 Drug Details PRI-724 (OP-724) is under development for the treatment of HCV or...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.